Displaying 25 - 36 of 120
Metabolism, Alcohol & Toxicity

Pathophysiological analysis of MASH: targetting clinical manifestations

Webcasts
View
Metabolism, Alcohol & Toxicity

Novo Nordisk: Addressing MASH as a liver manifestation of the metabolic disease (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

Summary and Closing remarks

Webcasts
View
Metabolism, Alcohol & Toxicity

Kickoff: The importance of early screening

Webcasts
View
Metabolism, Alcohol & Toxicity

Understanding burden of  MASLD: The Importance  on Quality of Life

Webcasts
View
Metabolism, Alcohol & Toxicity

Panel discussion

Webcasts
View
Metabolism, Alcohol & Toxicity

Approaching MASH as a metabolic disease with the need for holistic therapy

Webcasts
View
Metabolism, Alcohol & Toxicity

Panel Discussion

Webcasts
View
Metabolism, Alcohol & Toxicity

Welcome and introduction

Webcasts
View
Metabolism, Alcohol & Toxicity

Novo Nordisk:Clinical harmonisation for improving NASH diagnosis (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

Addressing NASH as a chronic metabolic disease: the need for a simplified patient referral pathway

Webcasts
View
Metabolism, Alcohol & Toxicity

Simplifying the patient referral pathway in NASH: expert opinion

Webcasts
View
Displaying 25 - 36 of 120